Abstract
Recently, the emergence of anti-CTLA-4 and anti-PD-1/PD-L1 antibodies called immune check-point inhibitors (ICPI) has modified the landscape of anti-cancer treatments. These therapeutics are associated with immune related adverse events that affect many organs, most commonly skin, digestive tract, endocrine glands and lungs. This review summarizes the main physiopathological hypotheses on the mechanisms of these toxicities. In most cases, the T lymphocytes hyperactivation induced by ICPI generates a specific response directed against tumor antigens, leading to anti-tumor activity in tumor tissues but also side effects in normal tisues called "on-target". The CD8+ cytotoxic T lymphocytes-mediated cell lysis induces the release of neoantigens, tumor antigens and auto-antigens from normal tissues, respectively. This phenomenon called "epitope spreading" leads to diversification of the T cell repertoire and thus to reduced immune tolerance, which is exacerbated by inhibition of regulator T lymphocytes. Furthermore, the predominant activation of Th1 and Th17T lymphocytes mediated by ICPI induced an increased production of pro-inflammatory cytokines such as interferon-γ (IFNγ) and interleukine-17 (IL-17). These two mechanisms are res...Continue Reading
Citations
Jan 30, 2019·Immunotherapy·Tian LiuYi Hu
Nov 16, 2019·Journal for Immunotherapy of Cancer·Satya Das, Douglas B Johnson
Nov 22, 2019·Pathologica·P GaffuriM Bergmann
Aug 23, 2020·International Journal of Molecular Sciences·Ana BocanegraGrazyna Kochan
Oct 5, 2019·Current Medicinal Chemistry·Parham Jabbarzadeh KaboliQinglian Wen
Dec 15, 2020·Technology in Cancer Research & Treatment·Tian ShenShusen Zheng
Oct 9, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yi-He LiuPeng Zhang
Jan 27, 2021·Urologic Oncology·Vincent T MaAjjai S Alva
Oct 22, 2020·IScience·Weilei HuMing You
Oct 23, 2020·BMC Cancer·Chiao-En WuJohn Wen-Cheng Chang
Nov 26, 2020·OncoTargets and Therapy·Tian-Ming CuiLian-Xin Liu
Feb 5, 2021·Cancer Management and Research·Wenhui LiuZhiying Luo
Mar 16, 2021·Immunotherapy·Chunlan WuXianhe Xie
Mar 7, 2021·Joint, Bone, Spine : Revue Du Rhumatisme·Leslie AddaAlice Séjourné
Mar 23, 2021·Frontiers in Oncology·Xiaoling ChenJian Fang
Jun 10, 2021·Journal of Hepatocellular Carcinoma·Cecilia MongeTim F Greten
Jul 14, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carolina A FerreiraUmar Mahmood
Nov 26, 2019·Case Reports in Oncology·Bożena Cybulska-StopaMaciej Niemiec